ReviewCancers2022

Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis.

Huimin Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.